It has been shown that Bcl-xL is essential for the survival of platelets 55, 56, thus indicating the challenge of targeting Bcl-xL with small molecules due to on-target toxicity of thrombocytopenia. This evidence concerns the gene BCL2L1 and Thrombocytopenia.